ASP Isotopes Inc. Files 8-K
Ticker: ASPI · Form: 8-K · Filed: Oct 23, 2025 · CIK: 1921865
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
ASP Isotopes filed an 8-K on 10/23/25, but it's light on details.
AI Summary
ASP Isotopes Inc. filed an 8-K on October 23, 2025, reporting other events and financial statements. The filing does not contain specific financial figures or details about the nature of the events reported.
Why It Matters
This filing indicates that ASP Isotopes Inc. has made a regulatory submission, but without further details, its immediate impact on investors or operations is unclear.
Risk Assessment
Risk Level: low — The filing is a standard procedural document with no immediate financial or operational disclosures that would indicate a change in risk.
Key Players & Entities
- ASP Isotopes Inc. (company) — Registrant
- October 23, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-41555 (identifier) — Commission File Number
- 87-2618235 (identifier) — IRS Employer Identification No.
- 601 Pennsylvania Avenue NW, South Building, Suite 900 Washington, DC 20004 (address) — Principal executive offices
- (202) 756-2245 (phone_number) — Registrant's telephone number
FAQ
What specific 'Other Events' are being reported by ASP Isotopes Inc. in this 8-K filing?
The filing does not specify the nature of the 'Other Events' beyond listing it as an item information category.
Are there any financial statements or exhibits included with this 8-K filing, and what do they pertain to?
The filing lists 'Financial Statements and Exhibits' as an item information category, but the content of these exhibits is not detailed in the provided text.
What is the primary business of ASP Isotopes Inc. based on its SIC code?
ASP Isotopes Inc. is classified under Standard Industrial Classification code 2890, which corresponds to Miscellaneous Chemical Products.
When was ASP Isotopes Inc. incorporated, and in which jurisdiction?
ASP Isotopes Inc. was incorporated in Delaware.
What is the principal executive office address and contact phone number for ASP Isotopes Inc.?
The principal executive offices are located at 601 Pennsylvania Avenue NW, South Building, Suite 900, Washington, DC 20004, and the contact number is (202) 756-2245.
Filing Stats: 519 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2025-10-23 17:06:13
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 ASPI The Nasdaq Stock Market LLC
Filing Documents
- aspi_8k.htm (8-K) — 26KB
- aspi_ex991.htm (EX-99.1) — 19KB
- aspi_ex991img2.jpg (GRAPHIC) — 3KB
- 0001477932-25-007716.txt ( ) — 175KB
- aspi-20251023.xsd (EX-101.SCH) — 5KB
- aspi-20251023_lab.xml (EX-101.LAB) — 15KB
- aspi-20251023_cal.xml (EX-101.CAL) — 1KB
- aspi-20251023_pre.xml (EX-101.PRE) — 10KB
- aspi-20251023_def.xml (EX-101.DEF) — 2KB
- aspi_8k_htm.xml (XML) — 4KB
01. Other Events
Item 8.01. Other Events. On October 23, 2025, ASP Isotopes Inc. (the "Company") issued a press release announcing that the Company's subsidiary, Quantum Leap Energy LLC, an advanced nuclear fuels company dedicated to the development of technology and processes across critical segments of the nuclear fuel cycle, has completed the purchase of certain assets from One 30 Seven Inc. to advance solutions for the processing of nuclear waste. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference, other than the ninth paragraph of the press release.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release, dated October 23, 2025, of ASP Isotopes Inc. announcing Quantum Leap Energy LLC has completed the acquisition of One 30 Seven Inc. assets to advance solutions for the processing of nuclear waste. 104 Cover Page Interactive Date File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASP ISOTOPES INC. Date: October 23, 2025 By: /s/ Donald G. Ainscow Name: Donald G. Ainscow Title: Executive Vice President, General Counsel and Secretary 3